International symposium on biology of cancer prevention and treatment.

[1]  S. Shuto,et al.  Targeting and anti-tumor efficacy of liposomal 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in mice lung bearing B16BL6 melanoma. , 2001, Cancer letters.

[2]  J. Yang,et al.  Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells. , 2001, Cancer letters.

[3]  W. Cavenee,et al.  Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. , 2001, Cancer Letters.

[4]  B. Brandt,et al.  Predictive laboratory diagnostics in oncology utilizing blood-borne cancer cells--current best practice and unmet needs. , 2001, Cancer letters.

[5]  K. Ayyanathan,et al.  Regulating the neoplastic phenotype using engineered transcriptional repressors. , 2001, Cancer letters.

[6]  K. Zänker,et al.  Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. , 2001, Cancer letters.

[7]  Y. Cheng,et al.  Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers. , 2001, Cancer letters.

[8]  K. Zanker,et al.  International symposium on biology of cancer prevention and treatment: Meeting report , 2000, International journal of cancer.

[9]  K. Zänker.  Chemoprevention of cancer for the next millennium--quo vadis? , 1999, Cancer letters.

[10]  G. Assmann,et al.  Isolation of blood‐borne epithelium‐derived c‐erbB‐2 oncoprotein‐positive clustered cells from the peripheral blood of breast cancer patients , 1998, International journal of cancer.

[11]  S. Lippman,et al.  Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.